FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine, namely to oncology, and can be used for qualitative and quantitative analysis of nonlinearly magnetised magnetocontrollable nanomedicines (MN) introduced in bodies of experimental animals, and real-time MN function evaluation. That is ensured by variation of MN responses to variable magnetic fields within electron-sensor scanning of an animal's body by an apparatus generating and emitting variable magnetic fields, receiving and recording MN responses found in a tumour and a liver. The response value indicates the presence and concentration of MN in experimental animals. The MN functions is shown by the relation of the tumour MN content to the liver MN content. If observing MNtumour> MNliver, MN can have therapeutic functions. MNtumour ≤MNliver shows MN exercising diagnostic functions.
EFFECT: method of analysis is noninvasive, informative and safe, and allows quantitative and qualitative analysis of MN distribution in the animal's body, and evaluation of the efficacy of route-specific MN concentration and immobilisation in a tumour.
3 tbl, 6 ex, 10 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF FERRIMAGNETIC-THERMOCHEMOTHERAPY OF MALIGNANT TUMOURS WITH COMBINATIONS OF MAGNETOCONTROLLABLE NANOMEDICINES WITH VISUALISATION OF ONCOGENESIS, DETEMINATION OF THERAPY PREFERABLE IN REAL TIME MODE AND MONITORING OF TREATMENT RESULTS IN EXPERIMENT | 2014 |
|
RU2563369C1 |
METHOD OF DETECTING TUMOR-FEEDING VESSELS IN EXPERIMENT | 2008 |
|
RU2382596C9 |
MEANS AND METHOD FOR EARLY EXPERIMENTAL CONTRAST MAGNETIC-RESONANCE TOMOGRAPHIC DETECTION OF MALIGNANT GLIAL TUMORS WITH FEEDING VESSELS | 2016 |
|
RU2655303C2 |
AGENT FOR EARLY CONTRAST DETECTION OF MALIGNANT PROLIFERATION CENTERS WITH FEEDING VESSELS, BOUNDARIES OF DIFFUSE INFILTRATION AND DETERMINATION OF STAGES OF THEIR DEVELOPMENT IN DYNAMICS | 2017 |
|
RU2692579C2 |
MEANS AND METHOD FOR COMBINED CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IMAGE VISUALIZATION OF BIOMECHANICS OF THE PROCESSES OF INFILTRATION, INVASION AND METASTASIS OF MALIGNANT CELLS | 2020 |
|
RU2761827C1 |
METHOD OF DIAGNOSTICS OF ONCOLOGIC DISEASES IN EXPERIMENT | 2007 |
|
RU2343828C2 |
METHOD FOR ASSESSING QUANTITATIVE ACCUMULATION OF A PARAMAGNETIC CONTRAST PREPARATION GDOF-Mn-DTPA FOR MAGNETIC RESONANCE IMAGING OF EXPERIMENTAL ANIMALS | 2018 |
|
RU2699334C1 |
METHOD FOR TREATING SOLID TUMORS BY APPLYING INDUCTIVE HYPERTHERMIA UNDER EXPERIMENTAL CONDITIONS | 2004 |
|
RU2291677C2 |
DETECTION, MEASUREMENT AND IMAGING OF CELLS, SUCH AS CANCER, AND OTHER BIOLOGICAL SUBSTANCES USING TARGETED NANOPARTICLES AND MAGNETIC PROPERTIES THEREOF | 2010 |
|
RU2587902C2 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
Authors
Dates
2011-08-27—Published
2009-06-08—Filed